title: Primary fallopian tube adenocarcinoma: preoperative diagnosis, treatment and follow-up.
abstract: Preoperative diagnosis of fallopian tube carcinoma is difficult due to the rarity and silent course of this neoplasm. We present herein the case of a 58-year-old woman with primary fallopian tube carcinoma that was diagnosed preoperatively on the basis of a positive for adenocarcinoma Papanicolaou vaginal smear, repeated episodes of vaginal bleeding, negative endocervical and endometrial curettage, characteristic features on ultrasonography and elevated CA-125 levels. The patient was treated by total abdominal hysterectomy, bilateral salpigno-oophorectomy and omentectomy. Pathologic confirmation of primary serous papillary adenocarcinoma of the left fallopian tube was made. Peritoneal washings were positive for malignancy. FIGO stage was considered as IIIb and the patient received six courses of combined carboplatin-taxol chemotherapy. At two years from onset of therapy the patient underwent a modified radical mastectomy and lymphadenectomy because of primary carcinoma of the right breast. The patient was started on tamoxifen therapy, which she is still taking. At 60 months after initial surgery, the patient is alive and well. In conclusion, our study suggests an association between fallopian tube carcinoma and breast cancer and a good response of the patient to platinum-based chemotherapy.
authors.affiliation: 3rd Department of Obstetrics and Gynaecology, University General Hospital ATTIKON, Athens, 3rd District National Health System, Athens (Greece). mnvarras@otenet.gr
authors.forename: M
authors.initials: M
authors.lastname: Varras
authors.forename: Ch
authors.initials: Ch
authors.lastname: Akrivis
authors.forename: A
authors.initials: A
authors.lastname: Bellou
authors.forename: V D
authors.initials: VD
authors.lastname: Malamou-Mitsi
authors.forename: N
authors.initials: N
authors.lastname: Antoniou
authors.forename: C
authors.initials: C
authors.lastname: Tolis
authors.forename: E
authors.initials: E
authors.lastname: Salamalekis
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology / Q000601:surgery; D018270:Carcinoma, Ductal, Breast / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology / Q000601:surgery; D003131:Combined Modality Therapy; D018283:Cystadenocarcinoma, Papillary / Q000175:diagnosis* / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000473:pathology / Q000601:surgery; D003937:Diagnosis, Differential; D004965:Estrogen Antagonists / Q000627:therapeutic use; D005185:Fallopian Tube Neoplasms / Q000175:diagnosis* / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000473:pathology / Q000601:surgery; D005260:Female; D006801:Humans; D008408:Mastectomy; D008875:Middle Aged; D009367:Neoplasm Staging; D011184:Postoperative Period; D011300:Preoperative Care; D013629:Tamoxifen / Q000627:therapeutic use; D014463:Ultrasonography
chemical_list: D004965:Estrogen Antagonists; D013629:Tamoxifen